Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder

Study design and implementation of the PRecision Medicine In MEntal health Care (PRIME Care) Trial

(2020) David W. Oslin et al.   Contemporary Clinical Trials

Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression

(2020) Anthony J. Rothschild et al.   PSYCHIATRY RESEARCH

VA Primary Care and Mental Health Providers’ Comfort with Genetic Testing: Survey Results from the PRIME Care Study

(2019) Leland E. Hull et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study

(2019) John F. Greden et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder?

(2017) Joshua D. Rosenblat et al.   JOURNAL OF CLINICAL PSYCHIATRY

Unknown

(2015)   CLINICAL PHARMACOLOGY & THERAPEUTICS

Polymorphism in CYP2D6 and CYP2C19, members of the cytochrome P450 mixed-function oxidase system, in the metabolism of psychotropic drugs

(2015) J. Stingl et al.   JOURNAL OF INTERNAL MEDICINE

The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults

(2011) Kelly Posner et al.   AMERICAN JOURNAL OF PSYCHIATRY

Validation and Standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the General Population

(2009) Bernd Löwe et al.   MEDICAL CARE

Selecting Among Second-Step Antidepressant Medication Monotherapies

(2008) A. John Rush et al.   ARCHIVES OF GENERAL PSYCHIATRY

Updated U.S. population standard for the Veterans RAND 12-item Health Survey (VR-12)

(2008) Alfredo J. Selim et al.   QUALITY OF LIFE RESEARCH